Objective. To assess the prevalence of prior tuberculin skin testing (TST) among populations at risk for HIV infection in Tijuana, Mexico, and 
In 2007, a study was conducted to identify the prevalence and correlates of Mycobacterium tuberculosis (MTB) and HIV infection among marginalized populations with high risk for HIV infection in Tijuana, Baja California, Mexico (1) . Test results using the QuantiFERON TB Gold in-Tube ® (QFT) interferon gamma release assay indicated that 57% of participants overall had latent tuberculosis infection (LTBI). Although the prevalence of HIV was only 4.2%, the selfreported risk behaviors associated with HIV infection were highly prevalent, suggesting that these groups were at risk for HIV/tuberculosis (TB) coinfection.
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of HIV-infected individuals globally are coinfected with TB, and TB is the leading cause of death among persons with AIDS, only 1% of persons living with HIV/ AIDS worldwide have been screened for TB (3) . It is therefore critical that individuals infected or at risk for infection with HIV be tested for TB early and often. A study in the four northern Mexico border states found that TB rates for Mexican-born persons were 5.0 times as high as those for persons born in the United States of America (4) . The state of Baja California, Mexico, situated across the border from California, United States, has a TB disease incidence rate of 57.3 per 100 000 population (the highest incidence of pulmonary TB in Mexico) (5) and has a policy of screening HIV-infected individuals for LTBI. It is unknown, however, whether individuals with HIV infection or those at high risk for HIV infection have been screened for TB. Therefore, the prevalence of prior tuberculin skin testing (TST) among populations at risk for HIV infection in Tijuana, Mexico was assessed and factors associated with prior TST were identified.
MATERIALS AND METHODS

Study population
The aims of the parent study were to measure the prevalence of LTBI and active TB disease among these groups and to identify correlates of infection. This cross-sectional study collected data from April to July 2007 among individuals recruited through targeted sampling in Tijuana. Eligibility included age ≥ 18 years, willingness to provide signed informed consent, no plans to leave Tijuana in the next 30 days, and reporting any of the following in the six months before recruitment: illicit drug use (other than marijuana), injection drug use, receiving money or goods in exchange for sex, and homelessness (includes unstable housing defined as living mainly in a rented hotel room, migrant work camp, or medical/drug treatment facility).
Participants were recruited through targeted sampling using street-based outreach, word of mouth, and advertising (1) . A recreational vehicle converted into a mobile health clinic was used to provide harm reduction education and basic health care services for high-risk populations and was used to access potential participants. All interviews were conducted at a storefront in a high-druguse neighborhood in Tijuana. The study protocol was approved by the University of California, San Diego, Institutional Review Board (IRB) and the Tijuana General Hospital Ethics Board. Further approval for this analysis was obtained from the San Diego State University IRB.
Data collection
Participant risk assessment data were collected during one-on-one private interviews. Interviews were conducted in Spanish by local staff highly familiar with the target population and experienced in gaining participants' trust so they felt comfortable providing honest responses to sensitive questions. The interviews assessed sociodemographics, risk factors for MTB and HIV infection, TB knowledge and exposure history, prior TB testing, and presence of TB-related symptoms. The survey instrument was developed in English, translated into Spanish, and then backtranslated into English to verify accuracy and meaning. After the interview, participants received pretest counseling and venipuncture for HIV and MTB testing. Monetary reimbursement equivalent to US$20 was given to participants for time and transportation.
Median age (36 years) was used to create a dichotomous age variable. Since very few participants identified as transgender, the male-to-female (MTF) group was categorized as female (No. = 10) and the female-to-male (FTM) group was categorized as male (No. = 3) for the purposes of this study. Lifetime measures included ever crossing the border into the United States; ever incarcerated (defined as having been detained in a jail, prison, or other adult detention center); country where incarceration occurred; and had health insurance in the past 6 months.
Self-reported lifetime history of sexually transmitted infections and positive TB results included only those diagnosed by a medical professional. TB knowledge was assessed using six TB knowledge questions:
• Can people have TB in their body that is sleeping and not an active form of disease?
• Participants were given one point for each correct answer and their combined scores, ranging from 0 to 6, were analyzed as a continuous variable. TST history was assessed by asking participants if they had ever had a skin test for TB.
Laboratory testing
TB infection was detected using the QuantiFERON TB Gold in-Tube ® assay ([QFT] Cellestis, Ltd. Carnegie, Australia), an in vitro test that detects infections but does not differentiate LTBI from active TB disease (6) . The detection of antibodies against HIV was obtained by using the Determine Rapid HIV Antibody Test (Abbot Laboratories, Boston, Massachusetts, United States). Positive results were confirmed by enzymelinked immunosorbent assay and immunofluorescent antibody assay at the San Diego County Public Health Laboratory. Participants with ≥ 1 acid fast bacillus-positive sputum smear or chest radiography readings consistent with TB diagnosis were determined likely to have active TB and were referred to the central public health clinic (Instituto de Servicios de Salud Pública del Estado de Baja California) for clinical confirmation and treatment through the national TB program (1). All participants were given an appointment to receive the results of their HIV and QFT tests, posttest counseling, and referrals for treatment as described elsewhere (1).
Statistical analyses
Variables were analyzed using means or medians for continuous measures and frequencies and percentages for categorical variables. The dependent variable for this analysis was self-reported lifetime history of TST (yes or no). Associations between independent variables and 
RESULTS
Only one participant answered "do not know" to the question on prior history of TST and was excluded; therefore, 502 participants were included in this analysis. Sixty-one percent of the sample were male (No. = 307), almost two-thirds were under 36 years old (No. = 264), and most (96.8%) were born in Mexico (No. = 487); however, 72.2% had ever crossed the border into the United States (No. = 363). Education was low, with only 10.9% completing more than a secondary school education (No. = 55), and 67.2% had ever been in jail (No. = 338). Thirty-eight percent of the sample reported ever receiving TST (No. = 191) and of those who had a previous skin test, 15 Self-reported treatment for active and latent TB infection was also investigated. 
Univariate analyses of factors associated with TST
The odds of a previous TST were greater among those older than 36 years (56.0% versus 42.1%), those who had crossed into the United States (86.9% versus 63.0%), those who had injected drugs in the past 6 months (59.2% versus 37.9%), and those who had ever been incarcerated (72.8% versus 19.0%) (all P < 0.05) ( Table 1 ). The odds of a prior TST were lower among those who reported sex work (17.3% versus 26.4%), those who tested HIV positive (0.01% versus 6.1%), and those who had ever been diagnosed with a sexually transmitted infection (0.52% versus 8.4%) (all P < 0.05). No other factors investigated were associated with TST.
Multivariate logistic regression model of factors associated with TST
Considering all variables were associated with P < 0.10 in univariate analysis, the following remained statistically significant at a level of 0.05 in multivariate analysis. The odds of previous TST were 13.4 times greater among those who were incarcerated in the United States (95% CI = 7.37-24.33). The odds of a previous TST were higher among those who injected drugs in the past 6 months (OR = 1.99, 95% CI = 1.27-3.11) ( Table 2) . After adjusting for these variables, age, gender, and travel to the United States were no longer significant. The HosmerLemeshow goodness-of-fit test statistic was 0.250 (> 0.05), indicating that the logistic model was a good fit.
DISCUSSION
This study showed that among individuals at high risk for HIV and MTB infection, the odds of having been screened for TB were higher among those with a history of incarceration, especially in jails in the United States. These results align with the U.S. Marshals Service TB policy, which requires that prisoners be tested as soon as conveniently possible after intake at a jail or detention center (7) . Previous studies have used jail as a forum to measure the spread and control of TB (8) (9) (10) . These data suggest that prisoners are accessing care and screening more often than those who are not incarcerated. While jails and detention centers are a potential avenue for providing care, it is clear that more options for testing should be available to high-risk individuals who are not incarcerated.
This study also found that after adjusting for incarceration, the odds of a previous TST were greater among injection drug users (IDUs), suggesting that IDUs might be targeted for TB screening more often than those who do not inject drugs. It is possible that IDUs are tested in drug treatment programs. However, participants were not asked where they received TST or about a lifetime history of drug treatment. This differs from previous studies, which have described IDUs as having difficulty completing medical evaluations (11) (12) (13) . Nonetheless, it is a positive finding given that IDUs are one of the highest risk groups for HIV infection in Mexico and that the prevalence of HIV among IDUs in Tijuana is increasing (14) . Further research should be conducted on IDUs and access to care to understand if it is a potential area for leveraging health promotion with regard to TB screening and treatment.
Serologic test results for MTB infection (i.e., QFT) and HIV were included in the analysis to determine whether those who had a prior TST were more or less likely to be QFT positive or HIV positive. No association was found between QFT results and prior TST in univariate and multivariate analyses.
Of concern was the finding that the odds of a previous TST were lower in HIV-positive participants than in HIVnegative participants even though TST is indicated for persons with HIV in Mexico. This finding was consistent, however, with prior reports showing that only 1% of individuals with HIV/ AIDS worldwide have a history of TST (3) . Further efforts are needed in Tijuana to ensure that all persons with HIV are screened for active TB disease and LTBI.
Self-reported treatment for active and latent TB infection was examined and it was found that of those who had reported prior TST and diagnosis with latent or active TB infection, the majority had been diagnosed in prison. Almost half of those who had been diagnosed with active TB reported stopping treatment early. This is consistent with a previous study also conducted in Tijuana in a population at high risk for HIV, which found a little over half of the population was able to finish treatment (15) .
Certain limitations should be considered in interpreting the study findings. The data collected for this study are cross-sectional, which limits our ability to determine the temporal relation between TST and the associated factors; therefore, none of the reported associations should be considered causal. Additionally, because the parent study was not designed to identify correlates of TST, some desired variables, such as place of testing and reasons for testing, were not assessed. Recall of lifetime factors could have led to misclassification of participants by TST status. However, since TST history was not an eligibility criterion for the study, such misclassification would likely be nondifferential; thus, bias would result in a reduction in the observed ORs toward the null and strengthens our confidence in the results.
In a population with a high prevalence of MTB infection and high risk for HIV infection, an increase in HIV infection could fuel an outbreak of active TB disease. It is therefore important for persons with, or at risk for, HIV infection to know Objetivo. Evaluar la prevalencia de la prueba de la tuberculina previa, e identificar los factores asociados con ella, en poblaciones con riesgo de infección por el VIH en Tijuana, México. Métodos. Se reclutó a profesionales del sexo, consumidores de drogas inyectables y no inyectables y personas sin hogar ≥ 18 años de edad mediante un muestreo dirigido a fin de efectuar entrevistas para evaluar el riesgo y pruebas serológicas para la infección por el VIH y Mycobacterium tuberculosis. Para identificar la correlación de los antecedentes de la prueba de la tuberculina proporcionados por el propio individuo se usó regresión logística de una sola variable y con múltiples variables.
Resultados. De 502 participantes, 38,0% informaron una prueba de la tuberculina previa, que se asoció con encarcelamiento anterior en los Estados Unidos de América (razón de posibilidades [OR] = 13,38; intervalo de confianza de 95% [IC] = 7,37-24,33) y consumo de drogas inyectables (OR = 1,99; IC de 95% = 1,27-3,11). Los resultados positivos en las pruebas serológicas para la infección con M. tuberculosis (57%) y VIH (4,2%) no se asociaron con una prueba de la tuberculina previa. Conclusiones. Los antecedentes de una prueba de la tuberculina fueron menores en los participantes seropositivos para el VIH, a pesar de que en México esta prueba está indicada en las personas con VIH. En este estudio menos de la mitad de los individuos con alto riesgo de VIH tenían antecedentes de la prueba de la tuberculina; sin embargo, esta fue bastante frecuente en los individuos con antecedentes de encarcelamiento. En las poblaciones en riesgo de contraer el VIH en Tijuana se requiere un mayor tamizaje de tuberculosis, en particular en aquellas no relacionadas con el ambiente de la justicia penal.
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